# De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

> **NCT01530997** · PHASE2 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 45 (actual)

## Conditions studied

- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
- Oropharyngeal Neoplasms

## Interventions

- **RADIATION:** Intensity Modulated Radiotherapy (IMRT)
- **DRUG:** Cisplatin
- **PROCEDURE:** Limited surgical evaluation

## Key facts

- **NCT ID:** NCT01530997
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-07
- **Primary completion:** 2014-11
- **Final completion:** 2019-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01530997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01530997, "De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01530997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*